AcrVIA6 Is a Monomeric DNA-Binding Protein That Does Not Directly Inhibit Cas13a.
Han, J.H., Lee, S.Y., Park, H.H.(2025) FASEB J 39: e70753-e70753
- PubMed: 40540289 
- DOI: https://doi.org/10.1096/fj.202500684R
- Primary Citation of Related Structures:  
9KJ9 - PubMed Abstract: 
The CRISPR-Cas system is a crucial adaptive immune mechanism in prokaryotes, providing defense against invading genetic elements. Among various CRISPR-Cas systems, the type VI-A system, employing RNA-guided RNase Cas13a, has been extensively studied for its ability to target and degrade single-stranded RNA. Anti-CRISPR (Acr) proteins have evolved as natural inhibitors of these systems, with AcrVIA proteins specifically targeting the Cas13a enzyme. However, there is currently conflicting debate regarding the anti-CRISPR function of AcrVIA6. This study reveals that AcrVIA6 functions as a DNA-binding protein rather than a Cas13a inhibitor, as it does not block RNA cleavage. These findings challenge its role in CRISPR-Cas regulation.
- College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Organizational Affiliation: 
















